Metronidazol Fresenius

Metronidazole, the active ingredient in Metronidazol Fresenius, is a nitroimidazole presented as an intravenous solution for intravenous use. It treats anaerobic bacterial infections and selected protozoal diseases in adults and children when prescribed by a qualified health professional.

GNH USA supplies Metronidazol Fresenius as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Metronidazole is employed to manage infections caused by anaerobic bacteria and certain protozoa. - Anaerobic bacterial infections: eradicates susceptible anaerobes, reducing tissue damage and systemic spread. - Bacterial vaginosis: restores normal vaginal flora by eliminating pathogenic anaerobes. - Trichomoniasis: eliminates Trichomonas vaginalis, relieving symptoms and preventing recurrence. - Amebic liver abscess: destroys Entamoeba histolytica trophozoites, aiding resolution of hepatic lesions. - Clostridioides difficile infection: suppresses toxin‑producing C. difficile, helping to control colitis.

Metronidazole may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Metallic taste: transient metallic sensation in the mouth. - Headache: occasional dull or throbbing pain. - Diarrhea: loose stools, usually self‑limiting. - Abdominal pain: cramping or discomfort in the abdomen. - Dizziness: light‑headed feeling, especially on standing.

Serious or Rare Side Effects: - Seizures: rare neurologic events requiring immediate care. - Peripheral neuropathy: tingling or numbness in extremities. - Severe allergic reactions: rash, swelling, or anaphylaxis. - Stevens‑Johnson syndrome: serious skin detachment. - Hepatic toxicity: elevated liver enzymes or hepatitis. - Neutropenia: marked reduction in white blood cells.

Before initiating therapy, consider the following safety measures. - Renal function assessment: adjust therapy if severe impairment exists. - Hepatic monitoring: check liver enzymes periodically during prolonged use. - Alcohol avoidance: abstain to prevent disulfiram‑like reactions. - Pregnancy caution: use only if benefits outweigh potential risks. - Dose adjustment in hepatic impairment: reduce dose according to clinical judgment. - Store at ambient temperature: keep in original container, protect from moisture and light.

Metronidazole can interact with several medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Alcohol: may cause severe flushing, tachycardia, and nausea. - Warfarin: potentiates anticoagulant effect, increasing bleeding risk. - Lithium: can raise lithium levels, leading to toxicity.

Moderate Interactions (Monitor Closely): - Cimetidine: may increase metronidazole plasma concentrations. - Carbamazepine: may reduce metronidazole effectiveness. - Oral contraceptives: may lower contraceptive efficacy, requiring additional protection.